Suppliers / Moehs

Moehs

Spain 233 employees 2 duplicate records merged Updated 9 July 2026

Moehs is an API manufacturer based in Spain. It holds 49 active US drug master files and 34 valid CEPs. Its GMP standing is certified by MFDS (Korea) and US FDA. Its most recent recorded inspection, by US FDA, closed on 24 November 2023 as VAI.

49
active US DMFs
34
valid CEPs
3
registered plants 2 with an FDA FEI number
1
filings across 1 regulators
These figures were checked against the regulators' own files on 25 July 2026
Plants
2 of 2 confirmed
Inspections
6 of 6 confirmed
Sources: FDA Establishment Registration, read 4 May 2026. FDA drug inspection classifications, read 4 May 2026.

Inspection history

  • 24 November 2023 VAI US FDA
  • 18 May 2018 VAI US FDA
  • 22 September 2017 VAI US FDA
  • 26 February 2016 VAI US FDA
  • 9 May 2013 VAI US FDA
  • 12 February 2010 VAI US FDA

NAI means no action indicated, VAI means voluntary action indicated, and OAI means official action indicated.

Registered plants

Site FDA FEI
Spain, Spain 3002807632
Rubi, Spain Not on file
Spain, Spain 3003245787

What they file, and where

Molecule Regulators Docs
Lidocaine EDQM, SFDA (Saudi Arabia), US FDA 5
Metoprolol EDQM, SFDA (Saudi Arabia), US FDA 5
Prilocaine EDQM, SFDA (Saudi Arabia), US FDA 5
Carvedilol EDQM, SFDA (Saudi Arabia), US FDA 4
Acetylcysteine EDQM, SFDA (Saudi Arabia), US FDA 3
Amlodipine EDQM, SFDA (Saudi Arabia), US FDA 3
Bisoprolol EDQM, SFDA (Saudi Arabia), US FDA 3
Bupivacaine EDQM, SFDA (Saudi Arabia), US FDA 3
Nifedipine EDQM, SFDA (Saudi Arabia), US FDA 3
Quetiapine EDQM, SFDA (Saudi Arabia), US FDA 3
Show all 30 molecules on file
Rabeprazole EDQM, SFDA (Saudi Arabia), US FDA 3
Sitagliptin SFDA (Saudi Arabia), US FDA 3
Acebutolol EDQM, US FDA 2
Amantadine EDQM, US FDA 2
Articaine EDQM, US FDA 2
Carbocisteine EDQM, SFDA (Saudi Arabia) 2
Celiprolol EDQM, US FDA 2
Dexmedetomidine US FDA 2
Lansoprazole EDQM, US FDA 2
Mepivacaine EDQM, US FDA 2
Norepinephrine EDQM, US FDA 2
Pantoprazole EDQM, US FDA 2
Sotalol EDQM, US FDA 2
Sumatriptan US FDA 2
Triamterene EDQM, US FDA 2
Abrocitinib US FDA 1
Amlodipine Besilate EDQM 1
Choline Fenofibrate US FDA 1
Daridorexant US FDA 1
Deucravacitinib US FDA 1

Also appears on these molecule pages

Acetylcysteine contract manufacturing Amlodipine contract manufacturing Bisoprolol contract manufacturing Carbocisteine API Carvedilol contract manufacturing Duloxetine contract manufacturing Fenofibrate contract manufacturing Irbesartan contract manufacturing Lansoprazole contract manufacturing Lidocaine contract manufacturing Lysine contract manufacturing Metoprolol contract manufacturing
Show 10 more molecule pages
Nifedipine contract manufacturing Olmesartan contract manufacturing Pantoprazole contract manufacturing Quetiapine contract manufacturing Sertraline API Sotalol contract manufacturing Sumatriptan contract manufacturing Telmisartan contract manufacturing Venlafaxine contract manufacturing Sitagliptin API

Filings and GMP by regulator

Regulator Filings GMP certificates
MINSA (CR) 5 None
MFDS (Korea) None 2
US FDA None 1

Comparing suppliers?

Choose your molecules and target markets. Moehs comes back tiered against every other supplier able to file there.

Start for free
No sales call.

Open risk flags

  • 3 active litigation matters are on record.
  • The most recent inspection outcome was VAI, on 24 November 2023.

Sources on this page

FDA
Drug master files, establishment registration, inspection classifications
EDQM
Certificates of suitability
EudraGMDP and national regulators
GMP certificates